Molecular identity · O-019
Mass spectrometry for peptide identity
Identity is an analytical conclusion, not a matching number. The value of a mass result depends on ion assignment, resolution, expected variants, reference evidence and whether sequence-level discrimination was needed.
Mass spectrometry can support peptide identity by comparing observed mass-to-charge signals with the expected molecule and, where needed, examining fragment ions or peptide maps. An intact mass close to the target does not by itself exclude sequence isomers, substitutions, truncations, modifications or mixtures, and it does not establish purity, quantity, sterility or clinical safety.
A strong identity record states the instrument approach, sample, expected and observed values, acceptance logic and any orthogonal confirmation. The laboratory should explain the level of identity the procedure was designed to establish.
Which level of identity was tested?
| Approach | What it can support | Important limit |
|---|---|---|
| Intact mass | Agreement between observed and expected molecular mass. | Different sequences or modifications can share or closely resemble a mass |
| Tandem MS | Fragment-ion evidence supporting parts of the sequence. | Coverage, fragmentation quality and interpretation rules matter |
| Peptide mapping | A pattern of fragments compared with a reference or expected map. | Digestion and separation conditions must be controlled |
| Orthogonal confirmation | Independent evidence from another analytical principle. | It strengthens a defined identity conclusion; it does not test unrelated attributes |
What should an identity report contain?
- Exact targetThe stated sequence, salt or counter-ion form, expected modifications and aliases must refer to the same entity.
- Observed resultLook for the measured ions, charge states, mass accuracy or matching criteria used by the laboratory.
- Reference basisA suitable reference standard, validated database, synthetic comparator or documented expected spectrum should support the assignment.
- AmbiguitiesThe report should state what the method cannot distinguish, including isomers, sequence variants or co-existing components.
- Sample provenanceIdentity attaches to the tested sample, not every item sold under the same product name.
Why can the right molecule still be a poor product?
A mass spectrum can show evidence consistent with the target molecule while leaving its amount, degradation products, residual solvents, elemental impurities and microbial quality unresolved. The presence of the expected molecule is not the same as a complete product-quality assessment.
Read identity beside chromatographic purity, assay, contaminants and microbiological tests. Each result needs its own method and sample link.
“The expected mass was observed” is narrower than “the sample is the correct peptide” and far narrower than “the vial is safe”.
A practical identity decision
Partial
An expected intact mass appears, but sequence discrimination or reporting detail is incomplete.
Continue the evidence check
Questions readers ask
Can mass spectrometry tell whether a peptide is genuine?
It can support the molecular identity of the tested sample when the procedure has enough discrimination for the question. It cannot authenticate a seller, prove how the sample was obtained or show that a separate vial contains the same material without a documented provenance chain.
Is the expected molecular weight enough?
Not in every case. Closely related sequences, modifications, salts, adducts and mixtures can complicate an intact-mass match. The laboratory should state whether intact mass provides enough specificity or whether tandem mass spectrometry, peptide mapping or another technique is needed.
Does LC-MS measure purity?
Liquid chromatography coupled to mass spectrometry can separate and detect components, but a purity percentage still depends on the validated procedure and calculation. An identity signal from MS does not automatically quantify every impurity or establish the absolute amount of peptide.
Can mass spectrometry prove sterility?
No. Molecular identity testing does not test sterility, bacterial endotoxin, microbial quality or particulate contamination. Those attributes need separate procedures and remain unknown when absent.
Primary sources and update triggers
- EMA: ICH Q2(R2) Validation of Analytical Procedures: validation for identity, assay, purity, impurities and other intended analytical purposes
- EDQM OMCL: Interpretation of screening results for unknown peptides: combining analytical approaches when peptide identity is uncertain
- EDQM: Technical guide for synthetic peptide monographs: orthogonal identity, chromatographic and peptide-mapping approaches
Editorial experience
From our work: how we checked this page
For topical-map item O-019, Mass spectrometry for peptide identity was checked as a distinct editorial task, not treated as a generic peptide page. We reviewed 3 unique external sources and 8 internal destinations in the page, then checked that the opening answer, headings, source descriptions and linked next steps stayed within the same claim boundary. The count records links in the published page and is not a claim that every source carries equal evidential weight.
Eleni Kiromitis checked the laboratory and scientific wording, drawing on direct experience commissioning laboratory tests and reviewing certificates of analysis and chromatograms. She checked whether each method was matched to the attribute it can measure, whether sample and batch limits remained visible, and whether the conclusion stopped where the analytical record stopped. Yianni Kiromitis retained responsibility for source verification, editorial decisions and correction management.
We did not use patient experience, a personal treatment outcome, seller testimony or an assumed product identity to support this page. The publication did not independently test a vial for this review. Where a page refers to a laboratory result, that result applies only to the named sample, method and attribute. We kept uncertainty beside the conclusion, recorded which source supports each material claim, and checked that the visible review date matches the publication record. A new controlled study, regulator update, corrected source, analytical report or credible safety signal can trigger reassessment through the public correction route.